Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

News
2019
2018
Archive

February 14, 2019

Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia
February 13, 2019

5AM Ventures Closes Two Life Science Venture Capital Funds
January 31, 2019

Audentes Therapeutics Announces Next Steps in the Development of AT132 to Treat XLMTM Following Collaborative Initial Meeting with FDA Under RMAT Designation
January 31, 2019

Kinestral Technologies Secures Over $100 Million in Series D Funding Led by SK Holdings
January 7, 2019

Homology Medicines Achieves 2018 Goals and Prepares PKU Gene Therapy Program for the Clinic with Initial Data Expected in 2019
January 7, 2019

Audentes Therapeutics Reports on Recent Progress and Outlines 2019 Key Priorities
January 6, 2019

Impel Neuropharma Announces Positive Phase 1 Trial For INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
January 4, 2019

Arvinas Receives Authorization To Proceed For Its IND Application For PROTAC™ Therapy
January 4, 2019

Pear Therapeutics Completes $64M Series C Financing
January 3, 2019

Cabaletta Bio Closes $50 Million Series B Financing to Establish Translational Research and Advanced Manufacturing Capabilities for Chimeric AutoAntibody Receptor (CAAR) T Cell Products to Treat B Cell-Mediated Autoimmune Diseases

1
2
3
…
48
Next Page »